ASCO 2021 Lung Caner – Luis G. Paz-Ares

Luis G. Paz-Ares explains which notable developments are taking place in the field of small-cell lung cancer with respect to new targets and targeted agents, how chemotherapeutic standards will change in the management of patients with small-cell lung cancer and highlights the most relevant findings presented at ASCO 2021 in terms of targeted therapies.

Here is the full ASCO 2021 Lung Cancer report.